SAGE logo

Sage Therapeutics (SAGE) Company Overview

Profile

Full Name:

Sage Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 18, 2014

Indexes:

Not included

Description:

Sage Therapeutics, Inc. is a biopharmaceutical company that specializes in the development and commercialization of drugs for the treatment of central nervous system disorders (depression, neuropsychiatric and neurological deviations). Founded in 2010, the company started its operations as Sterogen Biopharma, Inc. in 2011, changed its name to the current one. The corporate headquarters is located in Cambridge, Massachusetts. At the moment, the company has one product that was approved by the FDA in March 2019, and its commercialization began in the second half of that year. ZULRESSO is a drug whose active ingredient is identical to a natural neuroactive steroid. It is used for the treatment of postpartum depression.

Key Details

Price

$7.28

Annual Revenue

$41.24 M(-52.30% YoY)

Annual EPS

-$6.59(+27.18% YoY)

Annual ROE

-63.37%

Beta

1.66

Events Calendar

Earnings

Next earnings date:

Apr 25, 2025

Recent quarterly earnings:

Feb 11, 2025

Recent annual earnings:

Feb 11, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 12, 25 Wedbush
Neutral
Feb 12, 25 Scotiabank
Sector Outperform
Feb 12, 25 Needham
Hold
Feb 12, 25 HC Wainwright & Co.
Neutral
Feb 12, 25 Canaccord Genuity
Hold
Jan 2, 25 Piper Sandler
Overweight
Dec 16, 24 Stifel
Hold
Nov 21, 24 TD Cowen
Hold
Nov 21, 24 RBC Capital
Sector Perform
Nov 20, 24 Needham
Hold

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Sage Therapeutics?
  • Does Sage Therapeutics pay dividends?
  • What sector is Sage Therapeutics in?
  • What industry is Sage Therapeutics in?
  • What country is Sage Therapeutics based in?
  • When did Sage Therapeutics go public?
  • Is Sage Therapeutics in the S&P 500?
  • Is Sage Therapeutics in the NASDAQ 100?
  • Is Sage Therapeutics in the Dow Jones?
  • When was Sage Therapeutics's last earnings report?
  • When does Sage Therapeutics report earnings?
  • Should I buy Sage Therapeutics stock now?

What is the ticker symbol for Sage Therapeutics?

The ticker symbol for Sage Therapeutics is NASDAQ:SAGE

Does Sage Therapeutics pay dividends?

No, Sage Therapeutics does not pay dividends

What sector is Sage Therapeutics in?

Sage Therapeutics is in the Healthcare sector

What industry is Sage Therapeutics in?

Sage Therapeutics is in the Biotechnology industry

What country is Sage Therapeutics based in?

Sage Therapeutics is headquartered in United States

When did Sage Therapeutics go public?

Sage Therapeutics's initial public offering (IPO) was on July 18, 2014

Is Sage Therapeutics in the S&P 500?

No, Sage Therapeutics is not included in the S&P 500 index

Is Sage Therapeutics in the NASDAQ 100?

No, Sage Therapeutics is not included in the NASDAQ 100 index

Is Sage Therapeutics in the Dow Jones?

No, Sage Therapeutics is not included in the Dow Jones index

When was Sage Therapeutics's last earnings report?

Sage Therapeutics's most recent earnings report was on Feb 11, 2025

When does Sage Therapeutics report earnings?

The next expected earnings date for Sage Therapeutics is Apr 25, 2025

Should I buy Sage Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions